This may, partially, explain the phenotype of abnormalities in CKD-mineral and bone disorder (CKD-MBD), in which reduced levels of 1,25(OH)2D3 promotes hypocalcemia, stimulating excessive PTH production and, in turn, accelerated bone turnover [124]. Here, PTH is linked to chronic kidney disease.